These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 29374616)

  • 1. Efficacy of Treatments for Opioid-Induced Constipation: Systematic Review and Meta-analysis.
    Nee J; Zakari M; Sugarman MA; Whelan J; Hirsch W; Sultan S; Ballou S; Iturrino J; Lembo A
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1569-1584.e2. PubMed ID: 29374616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and meta-analysis.
    Ford AC; Brenner DM; Schoenfeld PS
    Am J Gastroenterol; 2013 Oct; 108(10):1566-74; quiz 1575. PubMed ID: 23752879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.
    Candy B; Jones L; Vickerstaff V; Larkin PJ; Stone P
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006332. PubMed ID: 29869799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological prevention and treatment of opioid-induced constipation in cancer patients: A systematic review and meta-analysis.
    Kistemaker KRJ; Sijani F; Brinkman DJ; de Graeff A; Burchell GL; Steegers MAH; van Zuylen L
    Cancer Treat Rev; 2024 Apr; 125():102704. PubMed ID: 38452708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence Based Review of Pharmacotherapy for Opioid-Induced Constipation in Noncancer Pain.
    Murphy JA; Sheridan EA
    Ann Pharmacother; 2018 Apr; 52(4):370-379. PubMed ID: 29092627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Oral Therapies for Opioid-induced Bowel Dysfunction in Patients with Chronic Noncancer Pain.
    Holder RM; Rhee D
    Pharmacotherapy; 2016 Mar; 36(3):287-99. PubMed ID: 26945548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review with meta-analysis: efficacy and safety of treatments for opioid-induced constipation.
    Vijayvargiya P; Camilleri M; Vijayvargiya P; Erwin P; Murad MH
    Aliment Pharmacol Ther; 2020 Jul; 52(1):37-53. PubMed ID: 32462777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights on efficacious doses of PAMORAs for patients on chronic opioid therapy or opioid-naïve patients.
    van Malderen K; Halawi H; Camilleri M
    Neurogastroenterol Motil; 2018 May; 30(5):e13250. PubMed ID: 29119706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review.
    Mehta N; O'Connell K; Giambrone GP; Baqai A; Diwan S
    Postgrad Med; 2016; 128(3):282-9. PubMed ID: 26839023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Peripherally Acting Mu-Opioid Receptor Antagonists for the Treatment of Opioid-Induced Constipation: A Bayesian Network Meta-analysis.
    Ouyang R; Li Z; Huang S; Liu J; Huang J
    Pain Med; 2020 Nov; 21(11):3224-3232. PubMed ID: 32488259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis of naldemedine for the treatment of opioid-induced constipation.
    Song X; Wang D; Qu X; Dong N; Teng S
    Expert Rev Clin Pharmacol; 2019 Feb; 12(2):121-128. PubMed ID: 30652502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and network meta-analysis.
    Luthra P; Burr NE; Brenner DM; Ford AC
    Gut; 2019 Mar; 68(3):434-444. PubMed ID: 29730600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripherally acting μ-opioid antagonist for the treatment of opioid-induced constipation: Systematic review and meta-analysis.
    Nishie K; Yamamoto S; Yamaga T; Horigome N; Hanaoka M
    J Gastroenterol Hepatol; 2019 May; 34(5):818-829. PubMed ID: 30597600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular Safety of the Selective μ-Opioid Receptor Antagonist Naloxegol: A Novel Therapy for Opioid-Induced Constipation.
    White WB; Kowey P; Diva U; Sostek M; Tummala R
    J Cardiovasc Pharmacol Ther; 2018 Jul; 23(4):309-317. PubMed ID: 29504415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid-induced constipation in chronic noncancer pain.
    Weber HC
    Curr Opin Endocrinol Diabetes Obes; 2016 Feb; 23(1):11-7. PubMed ID: 26702846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripherally Acting μ-Opioid Receptor Antagonists for the Treatment of Opioid-Related Side Effects: Mechanism of Action and Clinical Implications.
    Streicher JM; Bilsky EJ
    J Pharm Pract; 2018 Dec; 31(6):658-669. PubMed ID: 28946783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs for Treating Opioid-Induced Constipation: A Mixed Treatment Comparison Network Meta-analysis of Randomized Controlled Clinical Trials.
    Sridharan K; Sivaramakrishnan G
    J Pain Symptom Manage; 2018 Feb; 55(2):468-479.e1. PubMed ID: 28919541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of opioid-induced constipation: focus on the peripheral μ-opioid receptor antagonist methylnaltrexone.
    Rauck RL
    Drugs; 2013 Aug; 73(12):1297-306. PubMed ID: 23881667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Off-label uses of alvimopan and methylnaltrexone.
    Rodriguez RW
    Am J Health Syst Pharm; 2014 Sep; 71(17):1450-5. PubMed ID: 25147168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging therapies for opioid-induced constipation: what can we expect?
    Roostaei G; Khoshnam Rad N; Fakhri B MS; Nikfar S; Abdollahi M
    Expert Opin Pharmacother; 2024 Sep; 25(13):1729-1738. PubMed ID: 39308446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.